TREATMENT OUTCOMES. I understand that the practice and my treating dentist cannot guarantee treatment outcomes. I am responsible for reviewing the treatment plan and asking any questions I may have prior to receiving treatment. I have the right to accept or reject treatment recommended by my treating dentist. By consenting to my dentist’s treatment plans, I acknowledge that I accept known risks and complications of such treatments. It is my responsibility to fully inform the dentist of my medical history, all medications or other drugs that I am using and otherwise truthfully answer all questions related to my care. It is also my responsibility to follow my dentist’s pre- and post-treatment instructions and oral care instructions. I acknowledge that failure to comply with these requirements may increase the chance of poor treatment outcomes.
TREATMENT OUTCOMES. Although Services can help patients meet their treatment goals, there is no guarantee that this will occur, and, in fact, Patient’s symptoms might initially worsen before improving.
TREATMENT OUTCOMES. Although Services can help patients meet their treatment goals, there is no guarantee that this will occur, and, in fact, Patient’s symptoms might initially worsen before improving. Patient’s Responsibilities. Patient shall be responsible for performing the following obligations so long as Patient remains a patient of KBFTT: As compensation for the Services performed by KBFTT, prior to the commencement of each session, Patient shall pay KBFTT $225 per fifty-minute session throughout the term of this Agreement. Since KBFTT does not accept insurance, it is Patient’s responsibility to submit claims for reimbursement to Patient’s insurance company, and to follow up on the status of any claims submitted. Patient will be honest with his/her Psychotherapist about his/her thoughts and feelings, and Patient will comply with the treatment plan, including completing any outside of session “homework” assignments, as established by Patient’s Psychotherapist. Patient shall conduct himself/herself in an honest, appropriate, and lawful manner when interacting with Psychotherapist and other members of KBFTT’s staff.
TREATMENT OUTCOMES. I understand that the practice and my treating provider cannot guarantee treatment outcomes. I am responsible for reviewing the treatment plan and asking any questions I may have prior to receiving treatment. I have the right to accept or reject treatment recommended by my treating provider. By consenting to my provider's treatment plans, I acknowledge that I accept known risks and complications of such treatments. It is my responsibility to fully inform the provider of my medical history, all medications or other drugs that I am using and otherwise truthfully answer all questions related to my care. It is also my responsibility to follow my provider's pre- and post-treatment instructions. I acknowledge that failure to comply with these requirements may increase the chance of poor outcomes.
TREATMENT OUTCOMES. At Xxxx Xxxxxxx Dermatology and Xxxx Xxxxxxx Dermatology Affiliate locations we take great efforts to be honest in all of the interactions with you as our valued patient. Aesthetics is not an exact science, and patient outcomes vary from patient to patient, and results are based solely on your individual response to the treatment(s). As it is not possible to predict or guarantee results, any payments made are for treatments performed, not for the specific result desired. -50% Deposit is due upon scheduling your appointment. The balance will be due on date of service, prior to treatment. -Ulthera/Thermage: 20% of the total fee is nonrefundable if the appointment is canceled with less than ONE WEEK of notice. -Sculptra: Full deposit is required. Nonrefundable if the appointment is canceled with less than ONE WEEK of notice. -Other procedures: 20% of the total fee is nonrefundable if the appointment is canceled with less ONE WEEK of notice. *Additional site locations and/or offices may have additional considerations or policies that may not be indicated by this form. Please ask your site location if there are any of these instances.
TREATMENT OUTCOMES. The third and final aim of this audit was to evaluate treatment outcomes for young people with transformation obsessions compared to those without such obsessions. Results from the current audit indicate that young people with transformation obsessions respond equally well to the standard E/RP-based CBT protocol, as compared to patients with other obsessions. The clinic data suggest that this treatment protocol is appropriate for individuals presenting with ‘transformation obsessions’ and does not require a modified treatment approach (e.g. extended or adapted protocols). Taken together, these findings suggest that transformation obsessions in paediatric OCD are not as rare a phenomenon as was previously thought and that, whilst somewhat unusual in content, they exhibit similar characteristics to other OCD symptoms and should therefore be formulated and treated as any other obsession. The audit indicates that this cohort positively responded to the ERP-based CBT protocol delivered by the specialist OCD service. The audit also does not support the association between transformation obsession and contamination that has been anecdotally reported in the adult literature, and cautiously note the association between these obsessions and ‘forbidden obsessions’ for clinicians.
TREATMENT OUTCOMES. When examining the association between acquired resistance to streptomycin or ethionamide and clinically relevant treatment outcomes, we focused our analysis on subjects who had good or poor outcomes and excluded those who were lost to follow-up and those whose strains were resistant at baseline (n = 546 total excluded for streptomycin, n = 375 total excluded for ethionamide). Of the 42 subjects whose strains developed resistance to streptomycin, n = 15 (35.7%) were excluded because they were lost to follow up. Among the remaining 27 subjects whose strains acquired resistance to streptomycin, 10 (37.0%) had poor treatment outcomes, compared to 56 (19.6%) of the 286 subjects whose strains did not acquire this resistance (crude OR 2.42, 95% CI 1.05 – 5.56, p = 0.03) (Table 4). Of the 24 risk factors mentioned previously, three were found to be confounding variables in the logistic regression model for streptomycin. These factors were: previous treatment with second-line injectable drugs, HIV status, and number of effective drugs being used to treat the current MDR TB infection. Controlling for these factors with multivariable logistic regression model, we found that subjects whose strains developed resistance to streptomycin had 35% greater odds of having poor treatment outcomes than those who remained susceptible, although this was not statistically significant (adjusted OR = 1.35, 95% CI 0.86 – 2.11, p = 0.20).
TREATMENT OUTCOMES. At Xxxx Xxxxxxx Dermatology and Xxxx Xxxxxxx Dermatology Affiliate locations we take great efforts to be honest in all of the interactions with you as our valued patient. Aesthetics is not an exact science, and patient outcomes vary from patientto patient, and results are based solely on your individual response to the treatment(s). As it is not possible to predict or guarantee results, any payments made are for treatments performed, not for the specific result desired.
